Healthcare - Biotechnology - NASDAQ - US
$ 88.69
-7.28 %
$ 5.63 B
Market Cap
-42.85
P/E
CASH FLOW STATEMENT
-437 M
OPERATING CASH FLOW
274 M
INVESTING CASH FLOW
119 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Blueprint Medicines Corporation
| Net Income | -507 M |
| Depreciation & Amortization | 11.7 M |
| Capital Expenditures | -16.1 M |
| Stock-Based Compensation | 92.7 M |
| Change in Working Capital | -41.1 M |
| Others | -24.1 M |
| Free Cash Flow | -453 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (507.0) | (557.5) | (644.1) | 313.9 | (347.7) | (236.6) | (148.1) | (72.5) | (52.8) | (40.3) | (20.9) |
| Depreciation & Amortization | 11.7 | 11.7 | 6.5 | 6.6 | 5.3 | 4.2 | 1.6 | 1.6 | 0.9 | 0.6 | 0.5 |
| Deferred Income Tax | 0 | 0 | 1.4 | 0.5 | (4.9) | 0 | (0.3) | 0.3 | 0.4 | 100 K | 4 K |
| Stock Based Compensation | 92.7 | 99.0 | 91.6 | 75.5 | 54.7 | 30.5 | 12.5 | 6.1 | 5.2 | 2.3 | 0.4 |
| Other Operating Activities | 6.9 | (1.7) | 269.6 | 6.2 | 5.0 | (4.4) | 32 K | 73 K | 0.1 | 85 K | 26 K |
| Change in Working Capital | (41.1) | (53.8) | (23.7) | (15.6) | 9.7 | 31.2 | 14.4 | 39.9 | 14.4 | 1.8 | 1.0 |
| Cash From Operations | (436.8) | (502.3) | (298.7) | 387.0 | (278.0) | (175.0) | (119.9) | (24.5) | (31.7) | (35.4) | (19.0) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (16.1) | (8.9) | (261.2) | (3.2) | (14.0) | (12.7) | (15.5) | (2.4) | (4.9) | (0.7) | (0.3) |
| Other Items | 290.1 | (140.6) | 35.4 | (431.1) | (2.5) | (148.4) | (60.3) | (216.3) | (1.2) | 0 | 0 |
| Cash From Investing Activities | 274.0 | (149.5) | (225.9) | (434.2) | (16.5) | (161.1) | (75.8) | (218.7) | (6.1) | (0.7) | (0.3) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 97.9 | 137.8 | 0 | 0 | 0 | (1.5) | (2.6) | (3.3) | (1.8) | 6.2 | 3.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 44 K | 424.0 | 50.7 | 35.3 | 13.2 | 6.0 | (1.0) | (0.1) | (2.0) | 74.8 | 14.9 |
| Cash From Financing Activities | 119.2 | 561.8 | 50.7 | 617.8 | 340.6 | 4.5 | 543.9 | 132.6 | 153.2 | 81.4 | 18.0 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (43.4) | (90.2) | (474.7) | 570.2 | 46.2 | (331.6) | 348.2 | (110.6) | 115.5 | 45.3 | (1.3) |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (452.9) | (511.2) | (559.9) | 383.9 | (292.0) | (187.7) | (135.4) | (26.9) | (36.6) | (36.1) | (19.3) |